Literature DB >> 10867846

Cord blood interleukin-10 levels are increased in preterm newborns.

A Blanco-Quirós1, E Arranz, G Solis, A Villar, A Ramos, D Coto.   

Abstract

UNLABELLED: Cell-mediated immunosuppression due to interleukin (IL)-10 may contribute to normal pregnancy. By contrast, delivery is associated with a predominance of T-helper-1 (Th1) cytokines (IL-12, interferon-gamma) and might be regarded as a graft rejection process. The aim of the study was to assess IL-10 and IL-12 levels in cord blood samples from newborns and their normal mothers in relation to the gestational age and type of delivery. Cord blood and serum samples were obtained from 31 term newborns (gestational age 38-42 weeks) and 40 preterm newborns (mean gestational age 32 weeks). Serum samples were obtained from 26 mothers of term newborns at birth. There were 18 term and preterm infants born by caesarean section. Measurements of IL-10 and IL-12 levels by ELISA were repeated in mothers 15 days after delivery and in 11 preterm infants (median 14 days of age). Cord blood IL-10 levels were significantly higher in preterm than in term newborns (median 17.0 versus 3.2 pg/ml, P = 0.0001), but were similar to term newborns and paired mothers (2.2 versus 1.0 pg/ml). Term and preterm newborns also showed similar cord blood IL-12 levels (median 349 versus 320 pg/ml), and these levels were significantly higher when compared to their paired mothers (median 14.5 pg/ml, P = 0.0003). Cord blood IL-10 levels showed a significant inverse correlation with gestational age (P = 0.0001). When preterm infants, at several weeks post-delivery, were compared to gestational age matched newborns, their IL-10 levels were similar (median 8.3 pg/ml) whereas IL-12 levels were clearly lower (147 pg/ml; P = 0.0007). The type of delivery (vaginal versus caesarean) did not influence cord blood IL-10 and IL-12 results.
CONCLUSION: Cord blood IL-10 levels are increased in preterm newborns and may be due to the immunosuppression occurring during pregnancy and to fetal immaturity because these levels are inversely correlated with gestational age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867846     DOI: 10.1007/s004310051299

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.

Authors:  Indu Malhotra; Peter Mungai; Eric Muchiri; John Ouma; Shobhona Sharma; James W Kazura; Christopher L King
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Second trimester maternal plasma levels of cytokines IL-1Ra, Il-6 and IL-10 and preterm birth.

Authors:  R J Ruiz; N Jallo; C Murphey; C N Marti; E Godbold; R H Pickler
Journal:  J Perinatol       Date:  2012-03-29       Impact factor: 2.521

3.  Cell-associated interleukin-8 in cord blood of term and preterm infants.

Authors:  J Dembinski; D Behrendt; A Heep; C Dorn; J Reinsberg; P Bartmann
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

4.  Bacteriological and Immunological Profiling of Meconium and Fecal Samples from Preterm Infants: A Two-Year Follow-Up Study.

Authors:  Marta Gómez; Laura Moles; Irene Espinosa-Martos; Gerardo Bustos; Willem M de Vos; Leónides Fernández; Juan M Rodríguez; Susana Fuentes; Esther Jiménez
Journal:  Nutrients       Date:  2017-11-27       Impact factor: 5.717

5.  Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, two strains isolated from human milk, to very low and extremely low birth weight preterm infants: a pilot study.

Authors:  Laura Moles; Esperanza Escribano; Javier de Andrés; María Teresa Montes; Juan M Rodríguez; Esther Jiménez; Miguel Sáenz de Pipaón; Irene Espinosa-Martos
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

Review 6.  The immunological landscape in necrotising enterocolitis.

Authors:  Steven X Cho; Philip J Berger; Claudia A Nold-Petry; Marcel F Nold
Journal:  Expert Rev Mol Med       Date:  2016-06-24       Impact factor: 5.600

7.  Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases.

Authors:  Jared Ehrhart; Paul R Sanberg; Svitlana Garbuzova-Davis
Journal:  J Cell Mol Med       Date:  2018-10-18       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.